Martin Forrest | Vice President of Investor Relations and Corporate Communications |
Aron Knickerbocker | Chief Executive Officer |
Helen Collins | Chief Medical Officer |
Bryan Irving | Chief Scientific Officer |
David Smith | Chief Financial Officer |
Steven Seedhouse | Raymond James |
Kennen MacKay | RBC Capital Markets |
Welcome to the Five Prime Therapeutics Fourth Quarter and Fiscal Year 2018 Earnings Call.
As a reminder, this conference call is being recorded. I'd now like to introduce your host for today's conference, Martin Forrest, Vice President, Investor Relations and Corporate Communications.
You may begin.
Thank you, Scarlett.